Sales rise 15.92% to Rs 3.35 crore
Net profit of Ishita Drugs & Industries rose 21.43% to Rs 0.17 crore in the quarter ended June 2022 as against Rs 0.14 crore during the previous quarter ended June 2021. Sales rose 15.92% to Rs 3.35 crore in the quarter ended June 2022 as against Rs 2.89 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales3.352.89 16 OPM %6.576.23 -PBDT0.260.22 18 PBT0.230.18 28 NP0.170.14 21Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app